REPLIGEN CORP Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One
REPLIGEN CORP (RGEN) had Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One of $101.41 million as of 2023-03-31, per its 10-Q filed 2023-05-02.
Discontinued › Notes › Investments › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost · last filed 2023-05-02
- 2023-03-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $101.41M.
- 2022-12-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $100.30M.
- 2016-12-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $19.55M.
- 2016-03-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $16.48M.
| Period end | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One |
|---|---|
| 2023-03-31 | $101.41M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $100.30M 10-Q · filed 2023-05-02 |
| 2016-12-31 | $19.55M 10-K · filed 2017-02-23 |
| 2016-03-31 | $16.48M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $17.69M 10-K · filed 2016-02-25 |
| 2015-09-30 | $20.78M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $23.15M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $23.25M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $23.09M 10-K · filed 2015-03-17 |
| 2014-09-30 | $18.16M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $16.27M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $21.55M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $21.79M 10-K · filed 2014-03-14 |
| 2013-09-30 | $20.74M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $20.81M 10-Q · filed 2013-08-07 |
| 2013-03-31 | $19.33M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $10.84M 10-K · filed 2013-03-15 |
| 2012-09-30 | $11.91M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $12.49M 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |